PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

TELEFLEX MEDICAL INCORPORATED

USPTO PatentsView assignee record — 143 granted patents across 34 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Explore the portfolio See the ranking
143
Total patents granted
34
CPC technology areas
18.0
Avg claims per patent
+7%
5-year filing velocity

The verdict

TELEFLEX holds 143 US patents across 34 technology areas — rank #2,716 of 50,000 tracked assignees.

#2,716
of 50,000 US assignees by volume
Top 11%
by Innovation Score (51.8/100)
18.0
avg claims per patent
+7%
filing velocity, last 5 yrs

Portfolio overview

TELEFLEX MEDICAL INCORPORATED has been granted 143 US utility patents between 2015 and 2025, placing TELEFLEX MEDICAL INCORPORATED at rank #2,716 across all assignees tracked by PlainPatent. This portfolio spans 34 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.0 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, TELEFLEX MEDICAL INCORPORATED is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 51.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 74 grants, compared with 69 in the 2015–2019 window — a +7% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. TELEFLEX MEDICAL INCORPORATED's 18.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 34 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark TELEFLEX MEDICAL INCORPORATED against peers pursuing similar technology classes.

How does TELEFLEX compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows TELEFLEX holds 143 patents — placing it at rank #2,716 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

TELEFLEX's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

510152025 20152016201720182019202020212022202320242025 10
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
TELEFLEX MEDICAL INCORPORATED patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 10 7.0%
2016 14 9.8%
2017 12 8.4%
2018 11 7.7%
2019 22 15.4%
2020 23 16.1%
2021 13 9.1%
2022 7 4.9%
2023 8 5.6%
2024 13 9.1%
2025 10 7.0%

Which technologies does TELEFLEX MEDICAL INCORPORATED patent most?

Top 15 of 34 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#2,716

Across all tracked assignees

Innovation Score

51.8 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does TELEFLEX MEDICAL INCORPORATED hold?
TELEFLEX MEDICAL INCORPORATED holds 143 US granted patents filed between 2015 and 2025, spanning 34 technology areas.
What is TELEFLEX MEDICAL INCORPORATED's Innovation Score?
TELEFLEX MEDICAL INCORPORATED has an Innovation Score of 51.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does TELEFLEX MEDICAL INCORPORATED focus on?
TELEFLEX MEDICAL INCORPORATED's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 95 patents. The company has filed patents in 34 CPC subclasses total.
Is TELEFLEX MEDICAL INCORPORATED's patent filing rate increasing or decreasing?
TELEFLEX MEDICAL INCORPORATED's recent filing velocity is +7% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for TELEFLEX MEDICAL INCORPORATED's patents?
TELEFLEX MEDICAL INCORPORATED's patents average 18.0 claims each. This falls within the standard range, providing solid legal coverage.
How is the TELEFLEX MEDICAL INCORPORATED patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

A61B technology

TELEFLEX MEDICAL INCORPORATED's primary CPC class — all holders and yearly trends
Top 50 patent holders

See where TELEFLEX MEDICAL INCORPORATED ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope